NCT01000467View on ClinicalTrials.gov

Pharmacokinetics Study for Probucol

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Healthy
Interventions
DRUG

probucol

group 3: 250 mg 1 tablet in the morning and evening

DRUG

probucol

group 1: 250 mg

DRUG

probucol

group 2: 250 mg 2 tablets at once in the morning

Trial Locations (1)

Unknown

Seoul national univeristy, Seoul

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY